IDEXX LABORATORIES INC (IX1.DE) Stock Analyst Ratings
Europe - Frankfurt Stock Exchange - FRA:IX1 - US45168D1046 - Common Stock
595.2 EUR
-8.4 (-1.39%)
ChartMill assigns a Buy % Consensus number of 81% to IX1.DE. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 687.11. This target is 15.44% above the current price.
IX1.DE was analyzed by 21 analysts. The buy percentage consensus is at 81. So analysts seem to be very confident about IX1.DE.
In the previous month the buy percentage consensus was at a similar level.
IX1.DE was analyzed by 21 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2021-08-13 | Credit Suisse | Maintains | Outperform |
| 2021-08-03 | Goldman Sachs | Maintains | Neutral |
| 2021-08-02 | Barclays | Maintains | Overweight |
| 2021-07-12 | Guggenheim | Downgrade | Buy -> Neutral |
| 2021-02-17 | Barclays | Initiate | Overweight |
IDEXX LABORATORIES INC / IX1.DE FAQ
What is the average price target for IDEXX LABORATORIES INC (IX1.DE) stock?
21 analysts have analysed IX1.DE and the average price target is 687.11 EUR. This implies a price increase of 15.44% is expected in the next year compared to the current price of 595.2.
How do analysts rate IDEXX LABORATORIES INC (IX1.DE)?
The consensus rating for IDEXX LABORATORIES INC (IX1.DE) is 80.9524 / 100 . This indicates that analysts generally have a positive outlook on the stock.